NASDAQ:GILD News 22 August 2025

Gilead Sciences (GILD) Stock Outlook Before the December 1, 2025 Open: Price, News, Analyst Ratings and Forecast

As the U.S. market prepares to reopen on Monday, December 1, 2025, Gilead Sciences, Inc. (NASDAQ: GILD) is trading close to its recent highs and remains one of the more closely watched large‑cap biotech names on Wall Street. At the

1 December 2025

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences Stock Soars on Patent Win and HIV Breakthroughs – Will the Rally Continue?

Key Facts – October 18, 2025 GILD Stock Price Rallies to New Heights Gilead’s stock has been on a tear in recent weeks, far outpacing the broader market. After trading in the high $110s earlier in October, GILD spiked 4.2%

18 October 2025

Biotechnology · Healthcare · Investment Analysis · NASDAQ:GILD · Pharmaceuticals · Stock Market

Global Biotech & Health Roundup: Breakthrough Drugs, Big Deals & Policy Shifts (Aug 21–22, 2025)

Pharmaceutical Industry News (Approvals, Trials & Deals) Biotech Startups & Funding Highlights Medical Research Breakthroughs & Publications Healthcare Policy & Public Health Developments Regulatory Updates from Agencies (FDA, EMA, etc.) Sources: Scientific press releases, company announcements, major news outlets (Reuters,

22 August 2025

Biotech · Healthcare · Industry News · NASDAQ:GILD · NASDAQ:IONS · NASDAQ:PRGN · NASDAQ:XOMA · NYSE:JNJ · Pharmaceuticals · Policy

NASDAQ:GILD News 22 August 2025 - 1 December 2025

Gilead Sciences (GILD) Stock Outlook Before the December 1, 2025 Open: Price, News, Analyst Ratings and Forecast

Gilead Sciences Stock Soars on Patent Win and HIV Breakthroughs – Will the Rally Continue?

Global Biotech & Health Roundup: Breakthrough Drugs, Big Deals & Policy Shifts (Aug 21–22, 2025)